Bcl2L13 is a ceramide synthase inhibitor in glioblastoma
Proceedings of the National Academy of Sciences of the United States of America (2014) - Comment
pubmed: 24706805  doi: 10.1073/pnas.1316700111  issn: 1091-6490  issn: 0027-8424 

Samuel A. Jensen, Andrea E. Calvert, Giora Volpert, Fotini M. Kouri, Lisa A. Hurley, Janina P. Luciano, Yongfei Wu, Alexandra Chalastanis, Anthony H. Futerman, Alexander H. Stegh